Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

Just looked on the Cellceutix site and they reference the UOB study as follows:

The University of Bologna in Italy plans on testing Kevetrin for efficacy against Acute Myelogenous Leukemia (AML). The planned Phase 1B is a multi-center, open-label, dose optimization trial with Kevetrin, administered intravenously with Cytarabine administered either subcutaneously or intravenously. The University of Bologna will source the funding for this trial and plans to initiate the trial once a higher MTD is achieved in the Phase 1 trial conducted at Dana-Farber.

So they are sourcing the funding, so anyone can be the "funder"..

Still not certain the referenced study on the UOB site is indeed the Kevetrin study, why not just say Kevetrin?